Can I Be Induced at 38 Weeks? ACOG Criteria, Bishop Score, and Risk Timeline

Yes, you can be induced at 38 weeks, but only when there is a medical reason — it is not offered electively at this gestational age in the United States. The American College of Obstetricians and Gynecologists (ACOG) draws a hard line at 39 weeks for elective induction, so a 38-week induction requires a documented indication such as preeclampsia, gestational diabetes requiring medication, cholestasis, or suspected placental insufficiency. Roughly 1 in 10 US births now happens via induction, and about 31 percent of all births are induced, but the 38-week subset is small and clinically driven. If you are asking because you are uncomfortable, the honest answer is that most clinicians will decline — and the evidence supports that caution.

What "38 Weeks" Actually Means in Clinical Dating

The single most important number in this conversation is not 38 — it is the dating accuracy behind that 38. A pregnancy counted at 38 weeks 0 days to 38 weeks 6 days sits in the "late preterm to early term" boundary zone, and a two-week dating error can silently move a fetus from 38 weeks to 36 weeks.

First-trimester ultrasound performed before 14 weeks is accurate to within plus or minus 5 to 7 days. Second-trimester ultrasound, done between 18 and 22 weeks, widens that to plus or minus 10 to 14 days. If your due date was set by last menstrual period alone and never confirmed by early ultrasound, a "38-week" induction could genuinely be a 36-week delivery.

This is why ACOG and the Society for Maternal-Fetal Medicine both recommend confirming gestational age with first-trimester ultrasound whenever possible. In plain terms: the calendar is only as reliable as the scan that set it.

The American College of Obstetricians and Gynecologists classifies 37 weeks 0 days through 38 weeks 6 days as "early term," distinct from "full term" (39 weeks 0 days to 40 weeks 6 days). That terminology shift, formalized in 2013, was not semantic housekeeping — it reflected outcome data showing measurable differences in neonatal respiratory and feeding outcomes between 38 and 39 weeks.

The 39-Week Rule: Why Elective Induction Stops There

The Arrive trial, published by Grobman and colleagues in the New England Journal of Medicine in 2018, randomized more than 6,000 low-risk first-time mothers to elective induction at 39 weeks versus expectant management. Elective induction at 39 weeks reduced cesarean delivery (18.6 percent versus 22.2 percent) and reduced pregnancy-related hypertension without increasing adverse perinatal outcomes.

That trial transformed practice — but it studied 39 weeks, not 38. Extrapolating its findings backward by one week is a category error that clinicians actively resist.

The reason is pulmonary maturation. Fetal lung surfactant production surges between 36 and 39 weeks. A fetus delivered at 38 weeks has, on average, measurably less surfactant reserve than one delivered at 39 weeks. Large cohort studies of early-term births show elevated rates of transient tachypnea of the newborn, respiratory distress syndrome, and NICU admission at 37 to 38 weeks compared with 39 weeks — even after adjusting for medical indication.

ACOG's 2019 clinical practice guideline on induction of labor is explicit: elective induction before 39 weeks 0 days should not be performed. The word "elective" is doing enormous work in that sentence.

Quantified Risk: 38 Weeks Versus 39 Weeks

The comparison below draws on early-term birth outcome literature and ACOG guidance. Numbers are approximate ranges reported across cohort studies; individual risk depends heavily on indication and fetal status.

Note the tension in the last two rows. For a pregnancy with a genuine indication — poorly controlled diabetes, for instance — the stillbirth and macrosomia risk at 38 weeks can exceed the neonatal respiratory risk of delivery. That is precisely the calculus an obstetrician is running.

This is the quantified comparison most consumer articles omit: it is not "38 is bad, 39 is good." It is a trade-off curve, and the indication determines which side of the curve you are on.

Medical Indications That Justify Induction at 38 Weeks

When a real indication exists, 38-week induction is not merely permissible — it is sometimes the safer choice. The indications below are the common ones clinicians document.

• Hypertensive disorders: preeclampsia with severe features, or chronic hypertension with superimposed preeclampsia, often warrants delivery at 37 to 38 weeks.
• Gestational diabetes requiring insulin or oral agents, or poorly controlled type 1 or type 2 diabetes, where stillbirth risk climbs with gestational age.
• Intrahepatic cholestasis of pregnancy, particularly with bile acid levels above 100 micromoles per liter, where stillbirth risk rises sharply after 36 to 37 weeks.
• Suspected fetal growth restriction with abnormal Doppler findings.
• Oligohydramnios (amniotic fluid index below 5 cm) or documented placental insufficiency.
• Chorioamnionitis or preterm premature rupture of membranes at or beyond 34 weeks.

Each of these carries its own timing threshold, and several are satisfied before 38 weeks. The clinical question is rarely "38 or 39?" in isolation — it is "what is the gestational age at which this specific risk crosses the delivery risk?"

The Bishop Score: Why 38-Week Inductions Often Fail

A 38-week cervix is, on average, less favorable than a 39-week cervix. The Bishop score — a 0 to 13 composite of cervical dilation, effacement, station, consistency, and position — predicts induction success. A score of 8 or higher generally indicates a favorable cervix; 6 or below suggests the cervix needs preparation first.

Here is the non-obvious mechanism: the cervix remodels through collagen degradation, increased water content, and inflammatory cytokine activity (including interleukin-8 and prostaglandin E2), and this process accelerates in the final weeks. At 38 weeks, a first-time mother's cervix is frequently still firm and closed — a Bishop score of 3 to 5. At 39 to 40 weeks, the same cervix is more likely to have begun ripening spontaneously.

Inducing a Bishop score of 4 without ripening measures roughly doubles the failed-induction rate compared with a score of 8 or above. That failure often ends in cesarean, which is why "just induce me early" can paradoxically raise the chance of surgery.

Favorable-score inductions succeed in roughly 80 to 90 percent of cases. Unfavorable-score inductions, without cervical preparation, may succeed in only 50 to 60 percent.

The Induction Timeline: What 38 Weeks Looks Like Hour by Hour

If a clinician agrees to proceed, the process has a predictable time course. This timeline reflects a typical nulliparous patient with a moderately unfavorable cervix at 38 weeks.

Total time from admission to delivery for a first-time mother induced at 38 weeks commonly runs 24 to 48 hours — occasionally longer. A second birth shortens this substantially, often to 12 to 24 hours. Patients frequently underestimate this: induction is not a switch, it is a marathon.

Misconceptions About 38-Week Induction

The most persistent misconception is that 38 weeks is "full term." It is not. It is early term, and the distinction is grounded in neonatal outcome data, not terminology preferences.

A second misconception: that induction always increases cesarean risk. The Arrive trial showed the opposite at 39 weeks for low-risk first births. The nuance is that induction at 38 weeks with an unfavorable cervix behaves differently — the benefit seen at 39 weeks does not reliably transfer one week earlier.

A third: that "natural" onset is always safer. For a pregnancy with cholestasis or severe preeclampsia, waiting for spontaneous labor can mean waiting for a stillbirth. Induction is sometimes the risk-reducing intervention, not the risk-adding one.

A fourth, quieter misconception involves the "cascade of interventions." It is real but frequently overstated. Continuous fetal monitoring, epidural, and operative delivery are more common in induced labors, but much of that association reflects the indications that prompted induction rather than the induction itself.

What to Actually Do If You Want a 38-Week Induction

Positive, concrete steps matter more than the abstract debate. Here is what actually moves the conversation forward.

• Ask your clinician to document the specific indication. If there is none, ask what the evidence says about elective induction at 38 weeks — and expect the 39-week answer.
• Request a Bishop score at your next visit. Knowing whether your cervix is favorable changes the counseling substantially.
• If an indication exists, ask about cervical ripening before oxytocin. Ripening with a Foley balloon or prostaglandin improves success rates for unfavorable cervices.
• Confirm your dating. Ask whether your due date was set by first-trimester ultrasound; if it was set by LMP alone, request a dating review.
• If you are uncomfortable and there is no medical indication, ask about expectant management with increased surveillance — nonstress tests and biophysical profiles — rather than early delivery.
• Write down your questions before the appointment. Induction counseling is time-pressured and easy to forget.

Red-flag symptoms that warrant immediate contact regardless of gestational age:

• Decreased fetal movement (fewer than 10 movements in 2 hours after 28 weeks)
• Severe headache, visual changes, or right-upper-quadrant pain (possible preeclampsia)
• Vaginal bleeding beyond light spotting
• Regular contractions before 37 weeks
• Fluid leaking from the vagina
• Intense itching, especially of palms and soles (possible cholestasis)

Limits of the Evidence and What Remains Uncertain

The honest limitation is that most 38-week induction data comes from observational cohorts, not randomized trials. The Arrive trial covered 39 weeks in low-risk patients; the 38-week population is heterogeneous by indication, which makes clean comparison difficult.

We do not have large randomized trials isolating elective induction at exactly 38 weeks in low-risk nulliparous patients, because such a trial would be ethically fraught given known neonatal respiratory risks. The guidance therefore rests on extrapolation from early-term birth outcomes and mechanistic understanding of pulmonary maturation.

There is also real uncertainty about long-term outcomes. Most studies track neonatal and maternal outcomes through the immediate postpartum period; childhood respiratory and neurodevelopmental follow-up beyond a few years is thinner. This is not a reason to avoid indicated delivery — it is a reason to be precise about what the evidence supports and what it does not.

The practical bottom line: 38-week induction is medically appropriate and often indicated, but it is not an elective choice in current US practice. The 39-week threshold is not arbitrary — it reflects a measurable maturation gradient in the fetal lung, and the decision to cross it early should be driven by a documented maternal or fetal indication, not by discomfort alone.